Section one: Contracting authority
one.1) Name and addresses
NHS England North East And Yorkshire
City Office Park 3 Leeds City Office Park Holbeck
Leeds
LS11 5BD
Country
United Kingdom
Region code
UKE - Yorkshire and the Humber
NHS Organisation Data Service
(Q72)
Internet address(es)
Main address
https://www.england.nhs.uk/north-east-yorkshire/
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
Reference number
NHSE1088
two.1.2) Main CPV code
- 85140000 - Miscellaneous health services
two.1.3) Type of contract
Services
two.1.4) Short description
NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.
Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement:
• a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK
• a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK
The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population.
The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines.
Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme.
Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year.
As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years.
Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025.
Eligible providers must:
• Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process.
• Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire.
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:
Locations/Lots:
Yorkshire & Humber:
• Lot 1 - North Lincolnshire and North East Lincolnshire
• Lot 2 - Hull
• Lot 3 - East Riding
• Lot 4 - Leeds
• Lot 5 - Bradford
• Lot 6 - Kirklees
• Lot 7 - Wakefield
• Lot 8 - Barnsley
• Lot 9 - Doncaster
North East and North Cumbria:
• Lot 10 - Newcastle Upon Tyne
two.1.6) Information about lots
This contract is divided into lots: Yes
two.1.7) Total value of the procurement (excluding VAT)
Lowest offer: £0.01 / Highest offer: £18.06 taken into consideration
two.2) Description
two.2.1) Title
Lot 1 - North Lincolnshire and North East Lincolnshire
Lot No
1
two.2.2) Additional CPV code(s)
- 85140000 - Miscellaneous health services
two.2.3) Place of performance
NUTS codes
- UKE13 - North and North East Lincolnshire
Main site or place of performance
Lot 1 - North Lincolnshire and North East Lincolnshire
two.2.4) Description of the procurement
NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.
Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement:
• a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK
• a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK
The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population.
Eligibility
The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines.
Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme.
Activity/funding
Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year.
As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years.
Delivery date
Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025.
Provider Eligibility Criteria:
Eligible providers must:
• Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process.
• Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire.
Contract Term:
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:
Location/Lot:
Yorkshire & Humber:
• Lot 1 - North Lincolnshire and North East Lincolnshire - service to commence by 01 September with an expiry 31 March 2029 - with option to extend for 2-years (1+1).
two.2.5) Award criteria
Quality criterion - Name: Patient Choice / Weighting: 100
Cost criterion - Name: Patient Choice / Weighting: 100
two.2.11) Information about options
Options: Yes
Description of options
The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 1 - North Lincolnshire and North East Lincolnshire - service to commence by 01 September with an expiry 31 March 2029 - with option to extend for 2-years (1+1).
two.2) Description
two.2.1) Title
Lot 2 - Hull
Lot No
2
two.2.2) Additional CPV code(s)
- 85140000 - Miscellaneous health services
two.2.3) Place of performance
NUTS codes
- UKE11 - Kingston upon Hull, City of
Main site or place of performance
Lot 2 - Hull
two.2.4) Description of the procurement
NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.
Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement:
• a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK
• a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK
The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population.
Eligibility
The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines.
Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme.
Activity/funding
Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year.
As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years.
Delivery date
Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025.
Provider Eligibility Criteria:
Eligible providers must:
• Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process.
• Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire.
Contract Term:
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:
Location/Lot:
Yorkshire & Humber:
• Lot 2 - Hull - service to commence by 01 September with an expiry 01 April 2026 with option to extend for 6-years (4+2).
two.2.5) Award criteria
Quality criterion - Name: Patient Choice / Weighting: 100
Cost criterion - Name: Patient Choice / Weighting: 100
two.2.11) Information about options
Options: Yes
Description of options
The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: • Lot 2 - Hull - service to commence by 01 September with an expiry 01 April 2026 with option to extend for 6-years (4+2).
two.2) Description
two.2.1) Title
Lot 3 - East Riding
Lot No
3
two.2.2) Additional CPV code(s)
- 85140000 - Miscellaneous health services
two.2.3) Place of performance
NUTS codes
- UKE12 - East Riding of Yorkshire
Main site or place of performance
Lot 3 - East Riding
two.2.4) Description of the procurement
NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.
Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement:
• a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK
• a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK
The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population.
Eligibility
The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines.
Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme.
Activity/funding
Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year.
As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years.
Delivery date
Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025.
Provider Eligibility Criteria:
Eligible providers must:
• Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process.
• Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire.
Contract Term:
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:
Location/Lot:
Yorkshire & Humber:
Lot 3 - East Riding - service to commence by 01 September with an expiry 31 March 2026.
two.2.5) Award criteria
Quality criterion - Name: Patient Choice / Weighting: 100
Cost criterion - Name: Patient Choice / Weighting: 100
two.2.11) Information about options
Options: Yes
Description of options
The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 3 - East Riding - service to commence by 01 September with an expiry 31 March 2026.
two.2) Description
two.2.1) Title
Lot 4 - Leeds
Lot No
4
two.2.2) Additional CPV code(s)
- 85140000 - Miscellaneous health services
two.2.3) Place of performance
NUTS codes
- UKE42 - Leeds
Main site or place of performance
Lot 4 - Leeds
two.2.4) Description of the procurement
NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.
Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement:
• a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK
• a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK
The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population.
Eligibility
The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines.
Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme.
Activity/funding
Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year.
As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years.
Delivery date
Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025.
Provider Eligibility Criteria:
Eligible providers must:
• Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process.
• Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire.
Contract Term:
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:
Location/Lot:
Yorkshire & Humber:
• Lot 4 - Leeds - service to commence by 01 September with an expiry 31 March 2030 with option to extend by 4-years.
two.2.5) Award criteria
Quality criterion - Name: Patient Choice / Weighting: 100
Cost criterion - Name: Patient Choice / Weighting: 100
two.2.11) Information about options
Options: Yes
Description of options
The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 4 - Leeds - service to commence by 01 September with an expiry 31 March 2030 with option to extend by 4-years.
two.2) Description
two.2.1) Title
Lot 5 - Bradford
Lot No
5
two.2.2) Additional CPV code(s)
- 85140000 - Miscellaneous health services
two.2.3) Place of performance
NUTS codes
- UKE41 - Bradford
Main site or place of performance
Lot 5 - Bradford
two.2.4) Description of the procurement
NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.
Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement:
• a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK
• a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK
The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population.
Eligibility
The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines.
Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme.
Activity/funding
Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year.
As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years.
Delivery date
Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025.
Provider Eligibility Criteria:
Eligible providers must:
• Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process.
• Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire.
Contract Term:
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:
Location/Lot:
Yorkshire & Humber:
• Lot 5 - Bradford - service to commence by 01 September with an expiry 31 March 2033.
two.2.5) Award criteria
Quality criterion - Name: Patient Choice / Weighting: 100
Cost criterion - Name: Patient Choice / Weighting: 100
two.2.11) Information about options
Options: Yes
Description of options
The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 5 - Bradford - service to commence by 01 September with an expiry 31 March 2033.
two.2) Description
two.2.1) Title
Lot 6 - Kirklees
Lot No
6
two.2.2) Additional CPV code(s)
- 85140000 - Miscellaneous health services
two.2.3) Place of performance
NUTS codes
- UKE4 - West Yorkshire
Main site or place of performance
Lot 6 - Kirklees
two.2.4) Description of the procurement
NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.
Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement:
• a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK
• a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK
The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population.
Eligibility
The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines.
Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme.
Activity/funding
Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year.
As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years.
Delivery date
Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025.
Provider Eligibility Criteria:
Eligible providers must:
• Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process.
• Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire.
Contract Term:
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:
Location/Lot:
Yorkshire & Humber:
• Lot 6 - Kirklees - service to commence by 01 September with an expiry 31 March 2032.
two.2.5) Award criteria
Quality criterion - Name: Patient Choice / Weighting: 100
Cost criterion - Name: Patient Choice / Weighting: 100
two.2.11) Information about options
Options: Yes
Description of options
The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Lot 6 - Kirklees - service to commence by 01 September with an expiry 31 March 2032.
two.2) Description
two.2.1) Title
Lot 7 - Wakefield
Lot No
7
two.2.2) Additional CPV code(s)
- 85140000 - Miscellaneous health services
two.2.3) Place of performance
NUTS codes
- UKE45 - Wakefield
Main site or place of performance
Lot 7 - Wakefield
two.2.4) Description of the procurement
NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.
Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement:
• a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK
• a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK
The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population.
Eligibility
The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines.
Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme.
Activity/funding
Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year.
As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years.
Delivery date
Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025.
Provider Eligibility Criteria:
Eligible providers must:
• Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process.
• Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire.
Contract Term:
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:
Location/Lot:
Yorkshire & Humber:
• Lot 7 - Wakefield - service to commence by 01 September with an expiry 30 September 2031.
two.2.5) Award criteria
Quality criterion - Name: Patient Choice / Weighting: 100
Cost criterion - Name: Patient Choice / Weighting: 100
two.2.11) Information about options
Options: Yes
Description of options
The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:
Lot 7 - Wakefield - service to commence by 01 September with an expiry 30 September 2031.
two.2) Description
two.2.1) Title
Lot 8 - Barnsley
Lot No
8
two.2.2) Additional CPV code(s)
- 85140000 - Miscellaneous health services
two.2.3) Place of performance
NUTS codes
- UKE31 - Barnsley, Doncaster and Rotherham
Main site or place of performance
Lot 8 - Barnsley
two.2.4) Description of the procurement
NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.
Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement:
• a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK
• a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK
The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population.
Eligibility
The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines.
Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme.
Activity/funding
Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year.
As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years.
Delivery date
Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025.
Provider Eligibility Criteria:
Eligible providers must:
• Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process.
• Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire.
Contract Term:
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:
Location/Lot:
Yorkshire & Humber:
• Lot 8 - Barnsley - service to commence by 01 September with an expiry 30 June 2028.
two.2.5) Award criteria
Quality criterion - Name: Patient Choice / Weighting: 100
Cost criterion - Name: Patient Choice / Weighting: 100
two.2.11) Information about options
Options: Yes
Description of options
The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:
Lot 8 - Barnsley - service to commence by 01 September with an expiry 30 June 2028.
two.2) Description
two.2.1) Title
Lot 9 - Doncaster
Lot No
9
two.2.2) Additional CPV code(s)
- 85140000 - Miscellaneous health services
two.2.3) Place of performance
NUTS codes
- UKE31 - Barnsley, Doncaster and Rotherham
Main site or place of performance
Lot 9 - Doncaster
two.2.4) Description of the procurement
NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.
Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement:
• a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK
• a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK
The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population.
Eligibility
The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines.
Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme.
Activity/funding
Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year.
As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years.
Delivery date
Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025.
Provider Eligibility Criteria:
Eligible providers must:
• Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process.
• Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire.
Contract Term:
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:
Location/Lot:
Yorkshire & Humber:
• Lot 9 - Doncaster - service to commence by 01 September with an expiry 30 September 2027.
two.2.5) Award criteria
Quality criterion - Name: Patient Choice / Weighting: 100
Cost criterion - Name: Patient Choice / Weighting: 100
two.2.11) Information about options
Options: Yes
Description of options
The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:
Lot 9 - Doncaster - service to commence by 01 September with an expiry 30 September 2027.
two.2) Description
two.2.1) Title
Lot 10 - Newcastle Upon Tyne
Lot No
10
two.2.2) Additional CPV code(s)
- 85140000 - Miscellaneous health services
two.2.3) Place of performance
NUTS codes
- UKC22 - Tyneside
Main site or place of performance
Lot 10 - Newcastle Upon Tyne
two.2.4) Description of the procurement
NHS England - North East and Yorkshire (the Relevant Authority) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.
Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement:
• a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK
• a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK
The Relevant Authority is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population.
Eligibility
The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines.
Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme.
Activity/funding
Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year.
As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years.
Delivery date
Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025.
Provider Eligibility Criteria:
Eligible providers must:
• Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process.
• Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire.
Contract Term:
To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:
Location/Lot:
North East and North Cumbria:
• Lot 10 - Newcastle Upon Tyne - service to commence by 01 September expiry 30 September 2030.
two.2.5) Award criteria
Quality criterion - Name: Patient Choice / Weighting: 100
Cost criterion - Name: Patient Choice / Weighting: 100
two.2.11) Information about options
Options: Yes
Description of options
The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:
Lot 10 - Newcastle Upon Tyne - service to commence by 01 September expiry 30 September 2030.
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Award of a contract without prior publication of a call for competition in the cases listed below
- The procurement falls outside the scope of application of the regulations
Explanation:
The Relevant Authority intends to award this contract under the Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.
There were no Conflicts of Interest.
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
Section five. Award of contract
Contract No
Lot 1 - North Lincolnshire and North East Lincolnshire
Lot No
Lot 1
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
20 August 2025
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Lincolnshire Community Health Services NHS Trust
Beech House, Witham Park, Waterside South
Lincoln
LN5 7JH
Country
United Kingdom
NUTS code
- UKE13 - North and North East Lincolnshire
NHS Organisation Data Service
RY5
Internet address
https://lincolnshirecommunityhealthservices.nhs.uk/contact-us
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £18.06
Lowest offer: £0.01 / Highest offer: £18.06 taken into consideration
Section five. Award of contract
Contract No
Lot 2 - Hull
Lot No
Lot 2
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
20 August 2025
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
City Health Care Partnership CIC
5 Beacon Way
Hull
HU3 4AE
Country
United Kingdom
NUTS code
- UKE11 - Kingston upon Hull, City of
Companies House
06273905
Internet address
https://www.chcpcic.org.uk/pages/head-office
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £18.06
Lowest offer: £0.01 / Highest offer: £18.06 taken into consideration
Section five. Award of contract
Contract No
Lot 3 - East Riding
Lot No
Lot 3
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
20 August 2025
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
City Health Care Partnership CIC
5 Beacon Way
Hull
HU3 4AE
Country
United Kingdom
NUTS code
- UKE11 - Kingston upon Hull, City of
Companies House
06273905
Internet address
https://www.chcpcic.org.uk/pages/head-office
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £18.06
Lowest offer: £0.01 / Highest offer: £18.06 taken into consideration
Section five. Award of contract
Contract No
Lot 4 - Leeds
Lot No
Lot 4
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
20 August 2025
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Leeds Community Healthcare NHS Trust
White Rose Office Park, Building 3 Millshaw Park Lane
Leeds
LS11 0DL
Country
United Kingdom
NUTS code
- UKE42 - Leeds
NHS Organisation Data Service
RY6
Internet address
https://leedscommunityhealthcare.nhs.uk/contact-us/
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £18.06
Lowest offer: £0.01 / Highest offer: £18.06 taken into consideration
Section five. Award of contract
Contract No
Lot 5 - Bradford
Lot No
Lot 5
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
20 August 2025
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Locala Community Partnerships CIC
Eddercliffe Health Centre, Bradford Road,
Liversedge
WF15 6LP
Country
United Kingdom
NUTS code
- UKE4 - West Yorkshire
Companies House
07584906
Internet address
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £18.06
Lowest offer: £0.01 / Highest offer: £18.06 taken into consideration
Section five. Award of contract
Contract No
Lot 6 - Kirklees
Lot No
Lot 6
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
20 August 2025
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Locala Community Partnerships CIC
Eddercliffe Health Centre, Bradford Road,
Liversedge
WF15 6LP
Country
United Kingdom
NUTS code
- UKE4 - West Yorkshire
Companies House
07584906
Internet address
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £18.06
Lowest offer: £0.01 / Highest offer: £18.06 taken into consideration
Section five. Award of contract
Contract No
Lot 7 - Wakefield
Lot No
Lot 7
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
20 August 2025
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Spectrum Community Health CIC
1 Navigation Walk, Hebble Wharf,
Wakefield
WF1 5RH
Country
United Kingdom
NUTS code
- UKE45 - Wakefield
Companies House
07300133
Internet address
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £18.06
Lowest offer: £0.01 / Highest offer: £18.06 taken into consideration
Section five. Award of contract
Contract No
Lot 8 - Barnsley
Lot No
Lot 8
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
20 August 2025
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Spectrum Community Health CIC
1 Navigation Walk, Hebble Wharf,
Wakefield
WF1 5RH
Country
United Kingdom
NUTS code
- UKE45 - Wakefield
Companies House
07300133
Internet address
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £18.06
Lowest offer: £0.01 / Highest offer: £18.06 taken into consideration
Section five. Award of contract
Contract No
Lot 9 - Doncaster
Lot No
Lot 9
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
20 August 2025
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Solutions 4 Health
Head Office Unit 1 Thames Court Richfield Avenue
Reading
RG1 8EQ
Country
United Kingdom
NUTS code
- UKJ1 - Berkshire, Buckinghamshire and Oxfordshire
Companies House
06475161
Internet address
https://www.solutions4health.co.uk/about-us/
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £18.06
Lowest offer: £0.01 / Highest offer: £18.06 taken into consideration
Section five. Award of contract
Contract No
Lot 10 - Newcastle Upon Tyne
Lot No
Lot 10
Title
NHSE1088 - Mpox Vaccination and Gonorrhoea Vaccination
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
20 August 2025
five.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Solutions 4 Health
Head Office Unit 1 Thames Court Richfield Avenue
Reading
RG1 8EQ
Country
United Kingdom
NUTS code
- UKJ - South East (England)
Companies House
06475161
Internet address
https://www.solutions4health.co.uk/about-us/
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £18.06
Lowest offer: £0.01 / Highest offer: £18.06 taken into consideration
Section six. Complementary information
six.3) Additional information
The Relevant Authority intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023.
All new services - All existing providers.
For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.
Details of individual making decisions:
Deputy Head of Public Health, Yorkshire and the Humber, NHS England (North East and Yorkshire).
Senior Commissioning Manager - North East and North Cumbria, NHS England (North East and Yorkshire).
Screening and Immunisation Place Lead North Lincolnshire and North East Lincolnshire Y&H Public Health Programmes Team NHS England (North East & Yorkshire).
Finance Manager - Direct Commissioning (HJ & PH), NHS England Regional Team - North East & Yorkshire.
North East and North Cumbria Public Health Commissioning Management Group.
There were no conflicts of Interest.
six.4) Procedures for review
six.4.1) Review body
NHS England North East And Yorkshire
City Office Park 3 Leeds City Office Park Holbeck
Leeds
LS11 5BD
Country
United Kingdom